Skip to content
Search

Latest Stories

Community pharmacists asked to help increased uptake of flu jabs amid concerns over low level of population immunity

Amid concerns over the impact that influenza could have this winter because of a lower level of population immunity, the government is setting ambitious targets for the national flu immunisation programme for 2021/2022 which stars this autumn.

In a jointly published letter by the Department of Health and Social Care (DHSC), Public Health England (PHE) and NHSE&I, community pharmacists have been asked to further support increased uptake rates and offer further protection to this vulnerable group of patients.


The regulator's uptake ambition is to achieve a minimum of 85 per cent in those aged 65 years and older; a minimum of 75 per cent uptake across the under 65 years clinical risk group, pregnant women and the aged 50 to 64 years; and at least 70 per cent uptake in children.

Additionally, the aim is to reduce levels of inequality with no group or community having an uptake of more than 5 per cent lower than the national average.

At the end of February 2021, the NHS vaccination services had vaccinated a record 80.9 per cent of those aged 65 years and over in England, exceeding the World Health Organization uptake ambition of 75 per cent. The services also achieved the highest recorded vaccination levels for frontline healthcare workers, 2- and 3-year-olds, and at-risk groups.

The letter also highlights the risk of a lower level of population immunity against influenza because of non-pharmaceutical intervention measures taken to protect the population in response to the Covid-19 pandemic. 

As restrictions lift and the population returns to pre-pandemic norms of social mixing and social contact, the letter draws attention to how this could result in the 2021/2022 winter having co-circulation of seasonal influenza virus (and other respiratory viruses) and Covid-19. 

With modelling suggesting the influenza impact could be up to 50 per cent larger than that typically seen, it reinforces the message that the vaccination programme will be essential to reduce pressure on the health and social care system this winter.

Contractors are advised to read the national flu immunisation programme update letter in full but a summary of the key information for contractors is provided below.

Eligible groups

The expanded influenza vaccination programme introduced in the 2020/21 season continues and the letter confirms that the vaccination of 50 to 64-year-olds will, as part of measures to protect those aged 50 years and older from the risk of hospitalisation, also continue as a temporary measure.

Therefore, those eligible for NHS influenza vaccination in 2021/22 from community pharmacies are:

  • those aged 18 to 49 years in clinical risk groups;
  • pregnant women;
  • those aged 50 years and over;
  • those in long-stay residential care homes;
  • carers;
  • close contacts of immunocompromised individuals; and
  • frontline health and social care staff employed by:
  • a registered residential care or nursing home;
  • registered domiciliary care provider;
  • a voluntary managed hospice provider; and
  • Direct Payment (personal budgets) and/or Personal Health Budgets, such as Personal Assistants.

The letter reinforces the Government’s expectation that all frontline health and social care workers should have an influenza vaccination to protect those they care for.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less